<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38472498</PMID><DateCompleted><Year>2024</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1432-8798</ISSN><JournalIssue CitedMedium="Internet"><Volume>169</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>13</Day></PubDate></JournalIssue><Title>Archives of virology</Title><ISOAbbreviation>Arch Virol</ISOAbbreviation></Journal><ArticleTitle>Modulation of plasmacytoid dendritic cell and CD4<sup>+</sup> T cell differentiation accompanied by upregulation of the cholinergic anti-inflammatory pathway induced by enterovirus 71.</ArticleTitle><Pagination><StartPage>73</StartPage><MedlinePgn>73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00705-024-05974-z</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a neurotropic enterovirus associated with hand, foot, and mouth disease (HFMD) fatalities. In this study, we investigated the impact of EV71 on plasmacytoid dendritic cells (pDCs) and CD4<sup>+</sup> T cells. The results showed that pDCs were promptly activated, secreting interferon (IFN)-α and inducing CD4<sup>+</sup> T cell proliferation and differentiation during early EV71 infection. This initiated adaptive immune responses and promoted proinflammatory cytokine production by CD4<sup>+</sup> T cells. Over time, viral nucleic acids and proteins were synthesized in pDCs and CD4<sup>+</sup> T cells. Concurrently, the cholinergic anti-inflammatory pathway (CAP) was activated, exhibiting an anti-inflammatory role. With constant viral stimulation, pDCs and CD4<sup>+</sup> T cells showed reduced differentiation and cytokine secretion. Defects in pDCs were identified as a key factor in CD4<sup>+</sup> T cell tolerance. CAP had a more significant regulatory effect on CD4<sup>+</sup> T cells than on pDCs and was capable of inhibiting inflammation in these cells.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Li</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Yunnan Medical Center for Pediatric Diseases, Yunnan Institute of Pediatrics, Kunming Children's Hospital, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Huang</LastName><ForeName>Rong-Wei</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Xiao-Ning</ForeName><Initials>XN</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, Kunming Children's Hospital, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xiang</LastName><ForeName>Xiao-Yi</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Yuan-Tao</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xing-Xing</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Kunming Children's Hospital, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Lv-Yuan</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Yunnan Medical Center for Pediatric Diseases, Yunnan Institute of Pediatrics, Kunming Children's Hospital, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Yunnan Medical Center for Pediatric Diseases, Yunnan Institute of Pediatrics, Kunming Children's Hospital, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin Yi</LastName><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Zouping People's Hospital, Binzhou, 256200, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of 2nd Infection, Kunming Children's Hospital, Zouping People's Hospital, Kunming, 650228, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiao-Mei</ForeName><Initials>XM</Initials><Identifier Source="ORCID">0000-0003-3944-906X</Identifier><AffiliationInfo><Affiliation>Kunming Key Laboratory of Children Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Province Clinical Research Center for Children's Health and Disease, Kunming, 650228, Yunnan, China. 1043443230@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No.81960294</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>82060192</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>202103AF140008</GrantID><Agency>Yunnan International Science and Technology Co-Laborotary of Allergic Disease</Agency><Country /></Grant><Grant><GrantID>202101AT070231</GrantID><Agency>Yunnan Basic Research Project</Agency><Country /></Grant><Grant><GrantID>202105AC160012</GrantID><Agency>Yunnan young and middle-aged academic and technical leaders (reserve) Project</Agency><Country /></Grant><Grant><GrantID>D-2019017</GrantID><Agency>Yunnan High-level Health technical Personnel training program</Agency><Country /></Grant><Grant><GrantID>2020-SW-11</GrantID><Agency>Kunming Health Science and technology personnel training project</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Austria</Country><MedlineTA>Arch Virol</MedlineTA><NlmUniqueID>7506870</NlmUniqueID><ISSNLinking>0304-8608</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015213" MajorTopicYN="N">Neuroimmunomodulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002454" MajorTopicYN="N">Cell Differentiation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38472498</ArticleId><ArticleId IdType="doi">10.1007/s00705-024-05974-z</ArticleId><ArticleId IdType="pii">10.1007/s00705-024-05974-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS (2011) Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 85:11809–11820</Citation><ArticleIdList><ArticleId IdType="pubmed">21900167</ArticleId><ArticleId IdType="pmc">3209289</ArticleId></ArticleIdList></Reference><Reference><Citation>Lo SH, Huang YC, Huang CG, Tsao KC, Li WC, Hsieh YC et al (2011) Clinical and epidemiologic features of Coxsackievirus A6 infection in children in northern Taiwan between 2004 and 2009. J Microbiol Immunol Infect 44:252–257</Citation><ArticleIdList><ArticleId IdType="pubmed">21524960</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T (2010) Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 9:1097–1105</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Second J, Velter C, Cales S, Truchetet F, Lipsker D, Cribier B (2017) Clinicopathologic analysis of atypical hand, foot, and mouth disease in adult patients. J Am Acad Dermatol 76:722–729</Citation><ArticleIdList><ArticleId IdType="pubmed">28027826</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Chang LY, Hsia SH, Huang YC, Chiu CH, Hsueh C et al (2002) The 1998 enterovirus 71 outbreak in Taiwan: pathogenesis and management. Clin Infect Dis 34(Suppl 2):S52–S57</Citation><ArticleIdList><ArticleId IdType="pubmed">11938497</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang HI, Shih SR (2015) Neurotropic enterovirus infections in the central nervous system. Viruses 7:6051–6066</Citation><ArticleIdList><ArticleId IdType="pubmed">26610549</ArticleId><ArticleId IdType="pmc">4664993</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BA, Pallansch MA (1995) Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res 39:195–205</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CY, Li JR, Ou YC, Chen WY, Liao SL, Raung SL et al (2015) Enterovirus 71 infection caused neuronal cell death and cytokine expression in cultured rat neural cells. IUBMB Life 67:789–800</Citation><ArticleIdList><ArticleId IdType="pubmed">26399559</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Hsia SH, Huang YC, Wu CT, Chang LY (2003) Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis 36:269–274</Citation><ArticleIdList><ArticleId IdType="pubmed">12539066</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffiths MJ, Ooi MH, Wong SC, Mohan A, Podin Y, Perera D et al (2012) In enterovirus 71 encephalitis with cardio-respiratory compromise, elevated interleukin 1beta, interleukin 1 receptor antagonist, and granulocyte colony-stimulating factor levels are markers of poor prognosis. J Infect Dis 206:881–892</Citation><ArticleIdList><ArticleId IdType="pubmed">22829643</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin TY, Twu SJ, Ho MS, Chang LY, Lee CY (2003) Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg Infect Dis 9:291–3</Citation></Reference><Reference><Citation>Ye N, Gong X, Pang LL, Gao WJ, Zhang YT, Li XL, et al (2015) Cytokine responses and correlations thereof with clinical profiles in children with enterovirus 71 infections. BMC Infect Dis 15:225</Citation></Reference><Reference><Citation>Frenz T, Graalmann L, Detje CN, Doring M, Grabski E, Scheu S, et al (2014) Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus. J Immunol 193:2496–503</Citation></Reference><Reference><Citation>Fitzgerald-Bocarsly P (1993) Human natural interferon-alpha producing cells. Pharmacol Ther 60:39–62</Citation></Reference><Reference><Citation>Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, et al (1999) The nature of the principal type 1 interferonproducing cells in human blood. Science 284:1835–7</Citation></Reference><Reference><Citation>Liao YT, Tsai HP, Wang SM et al (2021) Clinical and immune responses of peripheral chemical sympathectomy in enterovirus 71 infection. J Front Immunol 12:700903</Citation><ArticleIdList><ArticleId IdType="pubmed">34566960</ArticleId><ArticleId IdType="pmc">8458799</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo J, Huo C, Qin H et al (2021) Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection. J Vaccine 39(30):4135–4143</Citation><ArticleIdList><ArticleId IdType="pubmed">34116877</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Z, Zhao R, Shen Y et al (2021) Low-frequency, exhausted immune status of CD56(dim) NK cells and disordered inflammatory cytokine secretion of CD56(bright) NK cells associated with progression of severe HFMD, especially in EV71-infected patients. J Int Immunopharmacol 101(Pt B):108369</Citation><ArticleIdList><ArticleId IdType="pubmed">34844872</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Pu J, Huang H et al (2013) EV71-infected CD14(+) cells modulate the immune activity of T lymphocytes in rhesus monkeys. J Emerg Microbes Infect 2(7):e44</Citation><ArticleIdList><ArticleId IdType="pubmed">26038477</ArticleId><ArticleId IdType="pmc">3820984</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong X, Zhou J, Zhu W, Liu N, Li J, Li L et al (2012) Excessive proinflammatory cytokine and chemokine responses of human monocyte-derived macrophages to enterovirus 71 infection. BMC Infect Dis 12:224</Citation><ArticleIdList><ArticleId IdType="pubmed">22994237</ArticleId><ArticleId IdType="pmc">3519709</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Liu H, Wang L, Yang F, Hu Y, Ren X et al (2013) Comparative study of the cytokine/chemokine response in children with differing disease severity in enterovirus 71-induced hand, foot, and mouth disease. PLoS One 8:e67430</Citation><ArticleIdList><ArticleId IdType="pubmed">23840697</ArticleId><ArticleId IdType="pmc">3696071</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Lei HY, Liu CC (2012) Cytokine immunopathogenesis of enterovirus 71 brain stem encephalitis. Clin Dev Immunol 2012:876241</Citation><ArticleIdList><ArticleId IdType="pubmed">22956971</ArticleId><ArticleId IdType="pmc">3432373</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie GC, Guo NJ, Grenman R, Wang H, Wang Y, Vuorenmma M et al (2016) Susceptibility of human tonsillar epithelial cells to enterovirus 71 with normal cytokine response. Virology 494:108–118</Citation><ArticleIdList><ArticleId IdType="pubmed">27107253</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervantes-Barragan L, Lewis KL, Firner S, Thiel V, Hugues S, Reith W et al (2012) Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci USA 109:3012–3017</Citation><ArticleIdList><ArticleId IdType="pubmed">22315415</ArticleId><ArticleId IdType="pmc">3286988</ArticleId></ArticleIdList></Reference><Reference><Citation>Muth S, Schutze K, Schild H, Probst HC (2012) Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity. Proc Natl Acad Sci USA 109:9059–9064</Citation><ArticleIdList><ArticleId IdType="pubmed">22615402</ArticleId><ArticleId IdType="pmc">3384145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadowaki N, Antonenko S, Lau JY, Liu YJ (2000) Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219–226</Citation><ArticleIdList><ArticleId IdType="pubmed">10899908</ArticleId><ArticleId IdType="pmc">2193254</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox JA, Hiscox JA, Solomon T, Ooi MH, Ng LFP (2017) Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front Microbiol 8:2249</Citation><ArticleIdList><ArticleId IdType="pubmed">29238324</ArticleId><ArticleId IdType="pmc">5713468</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasti M, Khanbabaei H, Teimoori A (2019) An update on enterovirus 71 infection and interferon type I response. Rev Med Virol 29:e2016</Citation><ArticleIdList><ArticleId IdType="pubmed">30378208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N, Li X, Li P, Pan Z, Ding Y, Zou D et al (2016) Enterovirus 71 inhibits cellular type I interferon signaling by inhibiting host RIG-I ubiquitination. Microb Pathog 100:84–89</Citation><ArticleIdList><ArticleId IdType="pubmed">27633794</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima K, Fujii T (2000) Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 86:29–48</Citation><ArticleIdList><ArticleId IdType="pubmed">10760545</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima K, Fujii T (2003) The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci 74:675–696</Citation><ArticleIdList><ArticleId IdType="pubmed">14654162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima K, Fujii T (2004) Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 9:2063–2085</Citation><ArticleIdList><ArticleId IdType="pubmed">15353271</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Luo H, Xiao X, Zhang H, Li T, Zuo X (2014) Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur J Pharmacol 735:97–104</Citation><ArticleIdList><ArticleId IdType="pubmed">24755145</ArticleId></ArticleIdList></Reference><Reference><Citation>Nizri E, Irony-Tur-Sinai M, Lory O, Orr-Urtreger A, Lavi E, Brenner T (2009) Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol 183:6681–6688</Citation><ArticleIdList><ArticleId IdType="pubmed">19846875</ArticleId></ArticleIdList></Reference><Reference><Citation>Galitovskiy V, Qian J, Chernyavsky AI, Marchenko S, Gindi V, Edwards RA et al (2011) Cytokine-induced alterations of alpha7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis. J Immunol 187:2677–2687</Citation><ArticleIdList><ArticleId IdType="pubmed">21784975</ArticleId></ArticleIdList></Reference><Reference><Citation>Song FX, Zhao LQ, Zhu RN, Song QW, Deng J, Tian R et al (2018) Protective effect of an alpha 7 nicotinic acetylcholine receptor agonist against enterovirus 71 infection in neuronal cells. Antiviral Res 149:106–112</Citation><ArticleIdList><ArticleId IdType="pubmed">29024766</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng HY, Huang YC, Yen TY, Hsia SH, Hsieh YC, Li CC et al (2014) The correlation between the presence of viremia and clinical severity in patients with enterovirus 71 infection: a multi-center cohort study. BMC Infect Dis 14:417</Citation><ArticleIdList><ArticleId IdType="pubmed">25069383</ArticleId><ArticleId IdType="pmc">4133623</ArticleId></ArticleIdList></Reference><Reference><Citation>Brioni JD, Kim DJ, O’Neill AB (1996) Nicotine cue: lack of effect of the alpha 7 nicotinic receptor antagonist methyllycaconitine. Eur J Pharmacol 301:1–5</Citation><ArticleIdList><ArticleId IdType="pubmed">8773440</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Phoon MC, Wu Y, Cutter J, James L, Chow VT (2011) The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect Dis 11:270</Citation><ArticleIdList><ArticleId IdType="pubmed">21988931</ArticleId><ArticleId IdType="pmc">3198955</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC (2009) Enterovirus 71: epidemiology, pathogenesis and management [J]. Expert Rev Anti Infect Ther 7(6):735–742</Citation><ArticleIdList><ArticleId IdType="pubmed">19681701</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Zhang R, Wu W, Duan G (2018) Antiviral and inflammatory cellular signaling associated with enterovirus 71 infection. Viruses 10</Citation></Reference><Reference><Citation>Santini SM, Di Pucchio T, Lapenta C, Parlato S, Logozzi M, Belardelli F (2002) The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity. J Interferon Cytokine Res 22:1071–1080</Citation><ArticleIdList><ArticleId IdType="pubmed">12513906</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert ML, Decalf J, Pol S (2008) Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C. J Hepatol 49:1069–1078</Citation><ArticleIdList><ArticleId IdType="pubmed">18929418</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald-Bocarsly P, Jacobs ES (2010) Plasmacytoid dendritic cells in HIV infection: striking a delicate balance. J Leukoc Biol 87:609–620</Citation><ArticleIdList><ArticleId IdType="pubmed">20145197</ArticleId><ArticleId IdType="pmc">2858309</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS (2004) Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 24:637–646</Citation><ArticleIdList><ArticleId IdType="pubmed">15622448</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Molen RG, Sprengers D, Binda RS, de Jong EC, Niesters HG, Kusters JG et al (2004) Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40:739–746</Citation></Reference><Reference><Citation>Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8:594–606</Citation><ArticleIdList><ArticleId IdType="pubmed">18641647</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306</Citation><ArticleIdList><ArticleId IdType="pubmed">15771572</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F et al (2001) BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194:1823–1834</Citation><ArticleIdList><ArticleId IdType="pubmed">11748283</ArticleId><ArticleId IdType="pmc">2193584</ArticleId></ArticleIdList></Reference><Reference><Citation>Hetzel M, Suzuki T, Hashtchin AR, Arumugam P, Carey B, Schwabbauer M et al (2017) Function and safety of lentivirus-mediated gene transfer for CSF2RA-deficiency. Hum Gene Ther Methods 28:318–329</Citation><ArticleIdList><ArticleId IdType="pubmed">28854814</ArticleId><ArticleId IdType="pmc">5734162</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M (2008) Phenotypic classification of human CD4<sup>+</sup> T cell subsets and their differentiation. Int Immunol 20:1189–1199</Citation><ArticleIdList><ArticleId IdType="pubmed">18635582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey KJ (2002) The inflammatory reflex. Nature 420:853–859</Citation><ArticleIdList><ArticleId IdType="pubmed">12490958</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>